Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
70.5M
-
Shares change
-
+4.29M
-
Total reported value, excl. options
-
$12.8B
-
Value change
-
+$832M
-
Put/Call ratio
-
1.39
-
Number of buys
-
192
-
Number of sells
-
-143
-
Price
-
$181.00
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q1 2021
382 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q1 2021.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.5M shares
of 114M outstanding shares and own 61.63% of the company stock.
Largest 10 shareholders include FMR LLC (9.74M shares), VANGUARD GROUP INC (6.53M shares), BlackRock Inc. (5.31M shares), MORGAN STANLEY (4.14M shares), ARK Investment Management LLC (3.5M shares), Foresite Capital Management II, LLC (2.25M shares), Meritech Capital Associates V L.L.C. (2.12M shares), 12 West Capital Management LP (1.92M shares), AMERIPRISE FINANCIAL INC (1.41M shares), and BAILLIE GIFFORD & CO (1.4M shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.